ESR1 and breast carcinoma: In addition, we evaluated MCM3 expression at the mRNA level in a large cohort (cohort 3) of ER+ breast cancer patients treated with endocrine therapy (n = 1802), ER+ patients who did not receive any systemic therapy (n = 503) as well as ER− breast cancer patients (n = 250).